Impact and significance of research. This study is the first one to assess the potential impact of several inflammatory markers on fat free mass and on the strength and bulk of the diaphragm and two limb muscles in stable patients with cystic fibrosis. It shows that this impact is very limited and that continued inflammation does not impede the response of the diaphragm to loading. Objectives. To assess the impact of systemic inflammation on diaphragm and limb muscle strength and bulk in adult patients with cystic fibrosis.
Introduction
Skeletal muscle wasting develops in a variety of chronic pulmonary and nonpulmonary disorders, including chronic obstructive pulmonary disease, congestive heart failure, uremia, cancer, and acquired immunodeficiency syndrome (1, 2) . The observation that cachexia develops in such a variety of chronic diseases suggests a common underlying mechanism. While nutritional deficiency, physical inactivity, and decreased plasma levels of anabolic hormones may all contribute to muscle wasting, there is growing evidence that systemic inflammation also plays a role. This evidence comes from measurements of circulating cytokines in humans, and from various in vivo and ex vivo experimental models (3) (4) (5) (6) (7) (8) . For example, in well-functioning elderly subjects with or without chronic obstructive pulmonary disease (COPD), higher circulating levels of tumor necrosis factor α and IL-6 are associated with lower quadriceps strength (9) . Collectively, these studies suggest that systemic inflammation is able to induce muscle wasting by the combined effects of inequity between muscle protein synthesis and degradation, and impaired muscle regeneration.
In cystic fibrosis (CF), systemic inflammation is likely more prolonged and pronounced than in many other chronic diseases. This inflammation results in part from "spillover" of pro-inflammatory cytokines produced in the chronically infected lungs to the central circulation (5) . In a previous study, we assessed quadriceps and diaphragm muscle bulk in 18 adult patients with CF (10) . We found that patients had smaller quadriceps mass and greater diaphragm mass than healthy controls, but diaphragm muscularity varied widely between patients. By multiple regression analysis, we found that fat free mass and airway resistance explained only ~ 50% of this variability. We hypothesized that the unexplained variance might be accounted for by the combined and opposite effects that systemic inflammation and the chronic increase in load resulting from airflow obstruction may have on the diaphragm; the former is expected to produce muscle wasting whereas the latter is expected to have a training effect and increase muscle bulk.
The primary aim of this study was to test this hypothesis, and the secondary aim was to assess the impact of systemic inflammation on peripheral muscles. We therefore studied 38 stable patients with CF and a wide range of disease severity, and 24 age-, sex-, and heightmatched healthy controls. We measured fat free mass, the strength of inspiratory and limb muscles, the thickness of the diaphragm and the cross-sectional area of the biceps and quadriceps, and circulating levels of several inflammatory markers. We found that systemic inflammation had no independent predictive effect on fat free mass and on inspiratory or limb muscle strength and bulk. Results of these studies have been reported in part in the form of an abstract (11) .
Methods (Word count = 529)
Subjects. We studied 38 adult patients with CF and 24 age-, sex-, and height-matched healthy subjects. Patients were clinically stable and were not treated by oral corticosteroids, anti-inflammatory agents, or azithromycin, but 28 received inhaled corticosteroids. Our previous study showed that fat free mass and airway resistance explained 51% of the variance in Tdi (10) . For a third variable (e.g, systemic inflammation) to reduce the residual variance by one fourth (12%) with a power of 0.85 (and a type I error of 0.05), Faul et al. (12) indicate that a sample size of 38 patients or more is needed.
All subjects gave written informed consent to the investigation, as approved by the Human Studies Committee of the Erasme University Hospital (Brussels, Belgium).
Pulmonary function. Spirometry and static lung volumes were measured using a computerized spirometer and a body plethysmograph (13) . Resting PaO 2 and PaCO 2 were measured while breathing room air.
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Inspiratory muscle strength. Mouth pressure (PIMAX) was measured in seated posture (14) , using a Hyp'Air equipment (Medisoft, Belgium). Measurements were performed at functional residual capacity in the patients and the controls; additional measurements were obtained in the latter at ~50 and ~25% of inspiratory capacity.
Diaphragm thickness. Diaphragm thickness (Tdi) was measured by ultrasound using a 6-15 MHz linear probe (Aloka, Wallingford, CT) (10) . Measurements were made in seated posture at functional residual capacity in the patients and the controls; additional measurements were obtained in the latter at ~50 and ~25% of inspiratory capacity.
Biceps and quadriceps strength. The maximum isometric strength of the biceps and quadriceps of the dominant arm and leg was measured using a hand-held dynamometer (Compufet, Biometrics, The Netherlands).
Biceps and quadriceps cross-sectional area. The cross-sectional area of the biceps and quadriceps of the dominant arm and leg was measured using computerized tomography (10).
Nutritional status. Nutritional status was assessed by computing body mass index (BMI), and by measuring fat free mass (FFM) and fat mass (FM) by electrical bioimpedance (Xitron Technologies Corporation, San Diego, CA).
Physical activity. We measured the level of leisure and occupational physical activity using the Modifiable Activity Questionnaire (15) , and peak oxygen uptake by cycle ergometry.
Markers of systemic inflammation. High-sensitivity C-Reactive Protein (CRP) and immunoglobulin G levels were measured according to standard techniques. Serum levels of Interleukin-6, -8, and -17, and Tumor Necrosis Factor-α (TNF-α) were measured by multiplex assays (Luminex, R&D Systems, USA), and TNF-α soluble receptors (sTNF-RI and RII) by ELISA (Biosource, Belgium). All data were log transformed.
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Data analysis. Data are expressed as means ± SD, unless otherwise specified. In each patient, values of PIMAX and Tdi obtained at FRC were compared to those obtained in a matched control subject at a similar absolute volume. Statistical analyses were made using paired and unpaired t-tests, single linear regression analysis, and covariance analysis, when appropriate. In addition, multiple stepwise forward regression analyses were performed to investigate the contribution of differences in gender, nutritional status, airflow obstruction, and systemic inflammation to the inter-patient variability in fat free mass and inspiratory and limb muscle strength and bulk. A level of p < 0.05 was considered statistically significant.
Additional details on patients and methods are given in the online data supplement. Tables 1 and E1 in the online data supplement summarize the characteristics of the patients and controls. They were well matched for age, height, and sex. Weight and body mass index were significantly reduced in the patients; fat free mass and fat mass showed a similar trend, but differences with the controls did not reach statistical significance. On average, the degree of airflow obstruction was moderate, but there was a wide range of disease severity (FEV 1 ranged between 15 and 113% of predicted). The level of daily physical activity and peak oxygen uptake were also reduced in the patients. Table 2 shows that patients had increased circulating levels of leucocytes, neutrophils, CRP, IL-6, -8, and -17, and sTNF-RI and RII. The degree of systemic inflammation varied considerably between patients; for example, CRP ranged between <0.07 and 4.0 mg/dl, IL-6 between 0.1 and 13.9 pg/ml, and TNF-α between 0.1 and 4.82 pg/ml. Although inhaled corticosteroids may reduce the level of TNF-α, and sTNF-RI and RII were increased in female, but not in male patients (see Table E4 in the online data supplement). Body mass index and FEV 1 were positively correlated with each other (r = 0.6; p = 0.002); on the other hand, FEV 1 was negatively correlated with logIL-17 (r = -0.43; p<0,05) and logCRP (r = -0.48; p=0.024), and BMI was negatively correlated with logIL-17 (r = -0.5; p = 0.02) and logIL-8 (r = -0.32; p<0.05). Levels of physical activity were correlated with quadriceps cross-sectional area (r = 0.49, p<0.01), but not with quadriceps strength (r = 0.27, p = NS). Table 3 summarizes values of inspiratory muscle strength, diaphragm thickness, and limb muscle strength and bulk in the two groups. Biceps and quadriceps strength and crosssectional area tended to be reduced in the patients, but differences with the controls did not reach significance. Figure 1A and 1B illustrate that biceps and quadriceps cross-sectional area was tightly correlated with fat free mass in the 2 groups, and that for any given fat free mass, patients and controls had similar muscle bulk.
Results
On the other hand, PIMAX and Tdi were greater in patients than in controls. The difference in Tdi was observed when values were compared both at a similar absolute lung volume and at FRC, irrespective of the patients' gender. Differences, however, were more significant for comparisons made at FRC and when Tdi was normalized by fat free mass (see Table E5 in the online data supplement). Otherwise stated, for any given fat free mass, patients had thicker diaphragms than controls (Figure 1 -by covariance analysis, the regression line in the patients was displaced towards higher values of Tdi, p<0.001); Figure 1 also shows that the correlation between diaphragm thickness and fat free mass was less tight in patients than in controls due to a greater between-subject variability in Tdi.
Single regression analyses were performed in the patients between inflammatory markers and muscle strength and bulk. Some negative correlations were found for limb muscle (for example, between biceps strength or quadriceps cross-sectional area and erythrocyte sedimentation rate or IL-17), but r values were low (< 0.5). For inspiratory muscle strength and diaphragm thickness, no correlation with inflammatory markers was found .
Results of multiple regression analyses performed in the patients are given in Table 4 .
Fat free mass was primarily predicted by gender and -sRaw, which accounted for 59% and 10% of the total variance, respectively; diaphragm thickness was best predicted by sRaw and fat free mass, which accounted for 25% and 22% of the total variance, respectively.
Inflammatory markers were not selected as independent predictors of fat free mass and diaphragm thickness. The regression equations for biceps and quadriceps strength and bulk identified fat free mass as primary independent variable, accounting for 69-84% of the total variance. Other factors like inflammatory markers or sRaw accounted for only very small percentages (1-7%) of the total variance.
Discussion
This study shows that in adult patients with mild to moderate CF: 1) the intensity of systemic inflammation correlates positively with the degree of airflow obstruction and the alteration in nutritional status; 2) the inspiratory muscles are stronger and the diaphragm is thicker in patients than in controls, which is consistent with a training effect and suggests that continued systemic inflammation does not prevent the response of the muscle to loading; and 3) the level of systemic inflammation is not an independent predictor of fat free mass, diaphragm thickness, inspiratory muscle strength, and limb muscle strength and bulk.
Critique of methods
Patient selection. This study compared CF patients to healthy adults. Caution is required before extrapolating these results to other chronic respiratory diseases such as non-CF bronchiectasis because CF is a genetic disorder which might affect many organ systems including the skeletal muscles (17, 18 ; see also the Discussion in the online data supplement).
On average, the patients studied here had less advanced disease than the patients of our previous study (10) , as evidenced by a higher FEV 1 (49 vs. 39% predicted) and a greater body mass index (19.8 vs. 17.8 kg/m 2 ). This is explained by the selection of patients with a large range of disease severity, including a few without significant airflow obstruction.
Assessment of Tdi.
Because diaphragm length is exquisitely sensitive to lung volume (19) , the diaphragm is expected to be thicker in hyperinflated patients than in controls when measurements are made at FRC. To control for this confounding effect, comparison of Tdi between groups was made at a similar absolute lung volume corresponding to the patients' FRC. However, for this comparison to be valid, the increase in FRC resulting from CF and the increase in volume achieved in the controls to match the patients' FRC should be similarly accommodated by the rib cage and the diaphragm-abdomen pathways -and hence produce similar changes in diaphragm length and configuration. Whether this assumption is true or not is unknown, but Bellemare et al. (20) recently reported that male and female CF patients do not accommodate pulmonary hyperinflation in the same way. Whereas both pathways shared the increase in FRC in males, it was primarily accommodated by rib cage expansion with preservation of diaphragm length in females. Based on these observations, it is difficult to know how Tdi should be compared between patients and controls. For this reason, we decided to provide values of Tdi obtained both at a similar absolute lung volume and at FRC, for each gender separately (see Table E5 in the online data supplement). Table E5 shows that Tdi was greater in patients than in controls, irrespective of the gender and of the volume at which the comparison was made, though differences were more significant when Tdi was normalized by fat free mass and when comparisons were made at FRC.
Inflammatory markers.
Because the aim of this study was to assess the potential effects of systemic inflammation on respiratory and limb muscles, it was appropriate to measure the levels of inflammatory markers in the serum, rather than in the bronchoalveolar lavage fluid or the sputum. We measured circulating levels of CRP, IL-6, IL-8, and TNF-α, which are well recognized markers of systemic inflammation in CF (21) . Furthermore, measuring levels of IL-6 and TNF-α was pertinent in the context of this study because these cytokines have the potential to induce skeletal muscle proteolysis via the ubiquitin-proteasome pathway (1). We also assessed IL-17; this is a newly described pro-inflammatory cytokine, which like IL-8 is critical for pulmonary neutrophil recruitment and host defence against Gram-negative bacteria and is increased in the sputum during acute exacerbations of CF (22) .
Previous study
In this study, we assessed overall inspiratory muscle, rather than diaphragm, strength.
We found that patients had increased PIMAX values, which contrasts with our previous finding that twitch transdiaphragmatic pressure is reduced in CF (10). The most likely explanation for this apparent discrepancy is that comparison of PIMAX between groups was made at a similar absolute lung volume, whereas twitch transdiaphragmatic pressure was compared at FRC.
Another difference with our earlier study is that we measured diaphragm thickness, rather than mass. Results of the two studies, however, were remarkably consistent in showing that CF is associated with an increase in diaphragm bulk (Table 3 and Figure 1C ) and does not similarly affect respiratory and limb muscles (see Figure E1 in the online data supplement). In addition, multiple regression analyses in both studies identified airway resistance as the principal independent predictor of diaphragm bulk, which strongly supports the view that thickening of the muscle occurs in response to loading.
Current study
As in earlier studies (23) (24) (25) (26) (27) (28) , this group of adult patients with CF who were clinically stable showed increases in several inflammatory markers that correlated with the severity of lung disease and the reduction in body mass index or fat free mass, i.e., the lower the FEV 1 and the BMI, the higher the degree of systemic inflammation. On the other hand, multiple regression analyses showed no independent predictive effect of inflammatory markers on the strength and bulk of inspiratory and limb muscles (Table 4) . This negative finding is particularly relevant in the context of this study which was designed with several strengths and novelties to reveal the potential effects of systemic inflammation. Firstly, we studied a group of patients who showed wide ranges of disease severity and inflammation, and were free of treatment with oral corticosteroids, anti-inflammatory agents, or azithromycin at the time of studies. Secondly, in addition to the impact of inflammation on fat free mass, we assessed the thickness of the diaphragm and the cross-sectional area of two limb muscles, which had not been done in earlier studies. Finally, we used multiple stepwise regression analyses to look for independent associations between inflammation and skeletal muscle function.
The results of the correlation analyses reported in Table 4 do not necessarily imply that systemic inflammation has no detrimental effect on skeletal muscles in CF. Firstly, measuring levels of circulating cytokines may not be the best way to assess the intensity of inflammation because soluble receptors and natural inhibitors may modulate their bioactivity.
In addition, inflammatory cytokines may exert part of their negative effects by increasing the generation of free radical species (29), which were not measured here. More importantly, measurements of cytokines were obtained at a single time point and hence cannot be considered as reflecting accurately the level of inflammation to which the patient (and his skeletal muscles) was exposed during the course of his longstanding disease. Ideally, a marker reflecting the level of inflammation over time, as does glycosylated hemoglobin for serum glucose, would be better suited, but such a marker does not exist. With this in mind, we included in the regression analyses two markers of sustained infection/inflammation -the levels of immunoglobulin G measured during the 2-year period preceding the study and the number of days of intravenous antibiotic treatment received during the same time period (see Table E1 in the online data supplement); these markers, however, did not perform better than circulating cytokines in predicting muscle function or bulk.
A last issue that may confound the demonstration of a negative effect of inflammation on skeletal muscles is the complex interplay between systemic and intramuscular factors, as discussed in previous reviews on patients with COPD (30, 31) . The former may include the duration and severity of the respiratory disease, the degree of hypoxemia and nutritional imbalance, and the circulating levels of cytokines, free radicals and anabolic hormones; the latter may include the degree of inactivity vs. muscle loading, muscle acidosis, and local concentrations of cytokines and free radicals (32) . This complex interplay will eventually determine if inflammation leads to muscle anabolism or catabolism. An illustration of this phenomenon is the observation that, depending on the context, local expression of TNF-α in skeletal muscles of COPD patients may be either beneficial, or detrimental to muscle regeneration (33, 34) .
The limitations discussed above may all apply to studies performed in patients with COPD and explain why these studies failed so far to establish unequivocally a causal link between systemic inflammation and skeletal muscle dysfunction (31, 35, 36) . By showing that this link can neither be demonstrated in a disease like CF, which produces much more pronounced and longstanding inflammation than COPD, the current studies emphasize the need for a better understanding of the influence of inflammation on muscle injury, regeneration and healing in chronic pulmonary disorders (31, 34) .
In summary, the current studies show that in patients with mild to moderate CF, the intensity of systemic inflammation does not account significantly for the variance in fat free mass, and diaphragm or limb muscle strength and bulk. Importantly, the presence of continued systemic inflammation does not seem impede the response of the diaphragm to loading. Definition of abbreviations: CF = cystic fibrosis; BMI = body mass index; FFM = fat free mass; FFMI= fat free mass index; FM = fat mass; TLC = total lung capacity; FEV 1 = forced expiratory volume in 1 sec; VC = vital capacity; FRC = functional residual capacity; RV = residual volume; sRaw = specific airway resistance; PaO 2 = arterial partial pressure of oxygen; PaCO 2 = arterial partial pressure of carbon dioxide; peak VO 2 = peak oxygen uptake (obtained in 31 patients); MAQ = modifiable activity questionnaire (13) .
CF patients (n = 38) Controls (n = 24) p value Age (years)
29. Definition of abbreviations: BicCSA = cross-sectional area of biceps muscle; BicPT = peak torque of biceps muscle; QuadCSA = cross-sectional area of quadriceps muscle; QuadPT = peak torque of quadriceps muscle; Tdi = diaphragm muscle thickness; PIMAX = maximum static inspiratory mouth pressure. Tdi and PIMAX were measured at a similar absolute lung volume in the patients and the controls. (Table E1 ). The patients, who were regularly attending the outpatient clinic of the hospital, were included if they were in clinically stable state, defined as no change in symptoms suggesting an exacerbation of respiratory infection or an acute concurrent illness, no reduction in FEV 1 of more than 10% of the patient's usual value, and no administration of intravenous antibiotic treatment in the month preceding the study. They all received treatment regimens consistent with current standards of care for CF.
Yet none of them took oral corticosteroids or anti-inflammatory agents, and in those who were treated by azithromycin, the drug was stopped at least 2 weeks before the study. Twentyeight patients were treated with inhaled corticosteroids. Our previous study showed that fat free mass and airway resistance explained 51% of the variance in Tdi (9) . Twenty healthy subjects who were matched for age, sex, and height with the patients and were non-smokers were studied as controls. All subjects were informed of the nature and extent of the study and gave written informed consent, as approved by the Human Studies
Committee of the Erasme University Hospital (Brussels, Belgium). Seven patients and 2
controls had participated to our previous study (E2) . were strongly encouraged to produce a maximum effort, with the help of the visual feedback provided on the screen. Efforts were maintained during 1.5 sec. Measurements were performed at functional residual capacity in the patients and the controls; additional measurements were obtained in the latter at volumes corresponding to ~50 and ~25% of inspiratory capacity. After a training period which allowed the subject to become accustomed to the equipment and the maneuver and to generate reproducible pressures, at lest 5 efforts that varied by less than 10% were obtained at each volume, and the 3 best values were averaged.
Diaphragm thickness. Diaphragm thickness (Tdi) was measured by ultrasound using a 6-15 MHz linear probe (Aloka, Wallingford, CT), as previously described (E5).
Measurements were made on a mid-coronal slice taken in the area where the right and left diaphragm are apposed to the lower rib cage. Acquisitions were made in seated posture during voluntary relaxation at functional residual capacity in the patients and the controls; additional measurements were obtained in the latter at volumes corresponding to ~50 and ~25% of inspiratory capacity. To attain these volumes, subjects were connected to a spirometer. At each volume, the average of at least 6 measurements of Tdi (3 on each side of the chest) was used for analysis. All measurements were performed by the same investigator (MC).
Biceps and quadriceps strength. The maximum isometric strength of the biceps and quadriceps of the dominant arm and leg was measured by using the Compufet system, a computer-assisted dynamometer (Biometrics, Almere, The Netherlands). The hand-held dynamometer was attached to the rigid arm of the biceps/quadriceps bench. For the biceps, the subject was in supine posture with the elbow at 90° and the forearm in neutral position;
for the quadriceps, the subject was sitting with the hip and knee at 90° (E6). Subjects were encouraged to produce a forceful elbow flexion and knee extension against the rigid arm of the quadriceps/biceps bench, and to sustain the isometric contraction for at least 3 seconds.
Throughout the effort, changes in peak torque (PT) over time were displayed on the computer screen to provide the subject with a visual feedback. The average of the 3 best plateau values of at least 5 consecutive, maximum voluntary contractions was used for analysis. For each muscle group, each effort was separated by a 2 min period of rest. All measurements were performed by the same investigator (CO). The average of three consecutive measurements was used for analysis.
Physical activity. Daily physical activity was assessed using the French translation of the Modifiable activity questionnaire (MAQ) (E9), which assesses both leisure and occupational physical activity over the past year. Only physical activities that demand energy expenditure greater than that required by activities of daily living are assessed. For the leisure section of the questionnaire, individuals were presented with a comprehensive list of activities and were asked to report the activities that they had participated in during the past 12 months.
They were then asked to estimate the frequency and duration for each activity identified. For occupational activity, individuals were asked to list all jobs held during the past 12 months.
For each job entry, data were collected for time spent walking or cycling to work per day, as well as the average job schedule (months per year, days per week, and hours per day worked).
Activity on the job was determined by the number of hours spent sitting at work and the most common physical activities performed when not sitting.
The level of physical fitness was assessed in 31 patients by measuring peak oxygen uptake; 7 patients were already breathless at rest and did not agree to perform the exercise test. The patients performed an incrementally progressive, symptom-limited, cardiopulmonary exercise test on an electrically-braked cycle ergometer, using standard techniques. After 5 min of adaptation to the mouthpiece, the workload was increased by 10-W steps every minute, to the point of exhaustion; the predicted value for peak oxygen uptake was derived from equations including sex, age, height, and weight (E10). Table E2 .
In addition to these serum markers, the average of all serum levels of immunoglobulin Data on within-subject repeatability of measurements of fat free mass, and respiratory and limb muscle strength and bulk are given in Table E3 .
Statistical analyses were made using paired and unpaired t-tests, single linear regression analysis, and covariance analysis. Holm's correction for multiple testing procedures Given the total number of patients, each regression analysis included only 3 independent variables that were selected based on our previous study (E2) . For fat free mass, the 3 variables were gender, specific airway resistance, and one variable reflecting systemic inflammation; for indexes of skeletal muscle strength and bulk, the 3 variables included fat free mass, specific airway resistance or FRC, and one variable reflecting systemic inflammation. R² values are reported to take into account the different number of predictors included in the models. A level of p < 0.05 was taken as statistically significant. Table E4 gives average values for leukocytosis and serum inflammatory markers for male and female patients and controls. Table E5 gives average values of strength and bulk of respiratory and limb muscles for male and female patients and controls. Levels of daily physical activity in the patients were correlated with quadriceps cross-sectional area (r = 0.49, p<0.01), but not with quadriceps strength (r = 0.27, p = NS). Figure E1 shows relationships between diaphragm thickness (Tdi) and quadriceps cross-sectional area in 38 patients with
Results
cystic fibrosis (open circles) and 24 controls (closed circles).
Discussion
Whereas levels of daily physical activity were markedly decreased in the patients, values of quadriceps strength and cross-sectional area were only mildly reduced, and physical activity was correlated with muscle bulk but not strength. These observations may be related to the fact that questionnaires are less accurate to quantify physical activity than objective methods like motion sensors (E13), but this is probably not the only explanation. In a recent study of 64 adult CF patients (who had decreases in FEV 1 and peak VO 2 similar to those of our patients), Troosters et al. (E14) found that physical activity levels assessed with motion sensors were only modest contributors to quadriceps weakness and exercise intolerance. The authors concluded that factors other than daily physical activity (or lung function impairment)
contribute to peripheral muscle weakness in these patients. Note: these data were collected retrospectively from patients' files. Table E2 . Characteristics of assays Sensitivity Range Inter-assay CV Intra-assay CV IL-6 0.36 pg/ml 0.53-3500 pg/ml < 8% < 5% IL-8 0.39 pg/ml 0.55-3600 pg/ml < 19% < 9% IL-17 0.39 pg/ml 0.34-2200 pg/ml < 8% < 6% TNF-α α α α 0.47 pg/ml 0.43-2800 pg/ml < 8% < 5% sTNF-RI 50 pg/ml 1-47 ng/ml < 9% < 7% sTNF-RII 0.1 ng/ml 2-142 ng/ml < 9% < 7%
Definition of abbreviations: See Table 2 ; CV = coefficient of variation. Tables 1 and 3 ; all data are expressed in %. By covariance analysis, the regression line in the patients is displaced towards higher values of Tdi (p<0.001).
